About FDA

Center for Tobacco Products

2013 Preceptor

Picture of Nicolette Borek

Nicolette Borek, Ph.D.
Office of Science/Center for Tobacco Products/FDA
9200 Corporate Boulevard, Rockville, MD 20850

Nicolette Borek is a Clinical Psychologist in the Office of Science, Center for Tobacco Products. She has worked with FDA for over a year as a member of the Addiction Team and the PATH Study management team. Dr. Borek joined FDA after working at the National Institutes of Health, National Institute on Drug Abuse (2002-2012) and National Institute of Mental Health (2000-2002).

Research Interests:

Clinical research including the development of nicotine addiction and dependence, youth tobacco initiation, and consequences of exposure to tobacco during development.

Proposed Regulatory Research Project for the FDA Commissioner's Fellow:

The Office of Science in the Center for Tobacco Products supports national epidemiologic surveys on tobacco use including the Population Assessment of Tobacco and Health (PATH) Study. The PATH Study is a National representative, longitudinal cohort study of 59,000 tobacco users and nonusers including 17,000 youth ages 12-17 in the U.S. The fellow will work with the PATH Study FDA Work Group and participate in day to day research activities as well as develop research projects related to tobacco product use and nicotine addiction and dependence. For more information on the study please visit the PATH website at http://www.pathstudyinfo.nih.gov. The Fellow will also have opportunities to work on other research projects related to addiction and dependence including work on other national surveys such as the National Adult Tobacco Survey (NATS) and the National Youth Tobacco Survey (NYTS).

Applicant Requirements:

Ph.D. or M.D. required. Clinical Psychologist, Psychiatrist, Physician with Addiction Medicine training or other Behavioral Scientist with addiction and dependence experience.

Selected Recent Publications:

Borek, N., Allison, S., & Caceres, C. (2010). Involving vulnerable populations of youth in HIV prevention clinical research. J Acquir Immune Defic Syndr. 54 Suppl 1:S43-49.

Sylvestre, D.L., Loftis, J.M., Hauser, P., Genser, S., Cesari, H., Borek, N. et al. (2004). Co-occurring Hepatitis C, substance use, and psychiatric illness: Treatment issues and developing integrated models of care. J Urban Health. 81(4):719-34.

Hann, D.M. & Borek, N. (2001). NIMH taking stock of risk factors for child/youth externalizing behavior problems. Washington, DC: U.S. Government Printing Office. NIH Publication No. 02-4938.


Page Last Updated: 05/26/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English